Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04742816 · ClinicalTrials.gov registry record · Phase 4
Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 42
- Enrollment target
NCT04742816 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 42 participants.
The verdict
NCT04742816, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 42 participants
- Enrollment target
Study Summary
Will use a subset of the main study cohort of transgender or non-binary individuals to evaluate the relationships between self-reported exogenous hormone use, endogenous hormone values, renal biomarkers, drug levels and directly measured renal function.
Interventions
- DRUG Iohexol
- DIAGNOSTIC_TEST IHX-CL measurements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2020-09-17 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04742816
The ClinicalTrials.gov registry entry for NCT04742816 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Iohexol is the first listed.
NCT04742816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04742816 about?
NCT04742816 is a clinical study titled "Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients". Will use a subset of the main study cohort of transgender or non-binary individuals to evaluate the relationships between self-reported exogenous hormone use, endogenous hormone values, renal biomarkers, drug levels and directly measured renal function.
What is the current status of trial NCT04742816?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2020-09-17. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT04742816?
The interventions under investigation include: Iohexol (DRUG), IHX-CL measurements (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04742816?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.